Skip to content

Anxiety: all studies

Page 245 of 772: studies 2,441 to 2,450 of 7,715, newest first. Back to the anxiety overview

Research

The role of ketamine in the treatment of treatment-resistant bipolar depression

Psychiatriki December 20, 2021 Grigorios N. Karakatsoulis, Eva-Maria Tsapakis, Konstantinos Ν. Fountoulakis 1 citation

Treatment-Resistant Depression (TRD) calls for the development of effective interventions for mood elevation and stabilization. Recently, both ketamine and its S-enantiomer (esketamine) have been investigated with successful clinical trials demonstrating effectiveness in TRD. More specifically, in 2019, intranasally administered esketamine, as opposed to the more effective intravenous ketamine,...

Effectiveness of online mindfulness interventions on medical students' mental health: a systematic review.

BMC Public Health December 18, 2021 Vaidehi Yogeswaran, Christo El Morr

Background: Medical school typically presents students with a combination of academic and personal stressors that may lead to substandard mental health wellbeing. Meditation practices such as mindfulness facilitate a greater awareness of one's thoughts and feelings, thereby decreasing emotional reactivity. The use of mindfulness-based interventions delivered online has considerable potential in...

Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study

Journal of Psychopharmacology December 17, 2021 Josephine Marschall, George Fejer, Pascal Lempe et al. 69 citations

Background: Microdoses of psychedelics (i.e. a sub-hallucinogenic dose taken every third day) can reduce symptoms of depression, anxiety and stress according to anecdotal reports and observational studies. Research with medium to high doses of psilocybin points towards potential underlying mechanisms, including the modulation of emotion and interoceptive processing. Aims: In this preregistered...

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Frontiers in Psychiatry December 17, 2021 John R. Kelly, Claire M. Gillan, Jack Prenderville et al. 66 citations

Accumulating clinical evidence shows that psychedelic therapy, by synergistically combining psychopharmacology and psychological support, offers a promising transdiagnostic treatment strategy for a range of disorders with restricted and/or maladaptive habitual patterns of emotion, cognition and behavior, notably, depression (MDD), treatment resistant depression (TRD) and addiction disorders,...

DOI: 10.3389/fpsyt.2021.800072 (opens in new tab) Anxiety Research domain criteria Psychotherapist Cognition +2

An experience with Holotropic Breathwork is associated with improvement in non-judgement and satisfaction with life while reducing symptoms of stress in a Czech-speaking population

Journal of Psychedelic Studies December 15, 2021 Malin V. Uthaug, Natasha L. Mason, Martha N. Havenith et al. 15 citations

Abstract Background Holotropic breathwork (Grof ® Breathwork), was developed by Stanislav Grof and Christina Grof as a ‘non-drug’ alternative technique to evoke altered states of consciousness (ASC). Interestingly, although HBW has been anecdotally reported to evoke experiences and mental health effects corresponding to those of psychedelic substances, the scientific literature on the matter is...

RECURRENT SLEEP PARALYSIS - FEAR OF SLEEPING

Revista Paulista de Pediatria December 14, 2021 Daniela Figueiredo Ramos, Joana Magalhães, Paulo Santos et al.

ABSTRACT Objective: To report a case of recurrent isolated sleep paralysis (RISP), a benign parasomnia with worrisome and frightening sleep paralysis episodes. Case description: We describe a case of RISP in a sixteen-year-old girl who seeks medical attention for anxiety symptoms. The sleep paralysis and associated auditory and tactile hallucinations began three years before with worsening in...

A Bibliometric and Visualization Analysis of Mindfulness and Meditation Research from 1900 to 2021

International Journal of Environmental Research and Public Health December 13, 2021 Yuzheng Wang, Lingqiu Liao, Xiaoxiao Lin et al. 30 citations

This study comprehensively summarizes research in the field of meditation, especially mindfulness meditation from 1900 to 2021, by analyzing the knowledge map through CiteSpace and VOSviewer software. Using “mindfulness *” or “meditation *” as the topic, articles included in the Science Citation Index Expanded and Social Sciences Citation Index were searched in the web of science core database,...

Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats.

Psychopharmacology December 2021 C M Ruiz, Alexa Torrens, Valeria Lallai et al.

Adolescent exposure to ∆9-tetrahydrocannabinol (THC), the psychotropic constituent of cannabis, might affect brain development, and in rodent models leads to long-term behavioral and physiological alterations. Yet, the basic pharmacology of this drug in adolescent rodents, especially when ingested via ecologically relevant routes like aerosol inhalation, commonly referred to as "vaping," is...

Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review

Nutrients November 20, 2021 Johanna Louise Keeler, Janet Treasure, Mario F Juruena et al. 55 citations

Anorexia nervosa (AN) is a highly complex disorder to treat, especially in severe and enduring cases. Whilst the precise aetiology of the disorder is uncertain, malnutrition and weight loss can contribute to reductions in grey and white matter of the brain, impairments in neuroplasticity and neurogenesis and difficulties with cognitive flexibility, memory and learning. Depression is highly...

Psychedelic medicines for mood disorders: current evidence and clinical considerations

Current Opinion in Psychiatry November 15, 2021 Jerome Sarris, Diego Pinzon Rubiano, Kimberley Day et al. 12 citations

Purpose of review Despite advances in treatment modalities for mood disorders over recent decades, further therapeutic options are still required. Increased research is occurring, with the pursuit of psychedelic-based pharmacotherapies for a range of mood disorders and other conditions. Recent findings Serotonergic psychedelics have been found to modulate brain networks underlying various...